Furthermore, coincubation of HepG2 cells with Lys-CoA-TAT (a cell-permeable p300 Head wear inhibitor) abolished the acetylation of ChREBP simply by p300 (Amount ?(Figure3E)
Furthermore, coincubation of HepG2 cells with Lys-CoA-TAT (a cell-permeable p300 Head wear inhibitor) abolished the acetylation of ChREBP simply by p300 (Amount ?(Figure3E).3E). which reduced ChREBP-mediated lipogenesis in mice and…